<DOC>
	<DOCNO>NCT02602860</DOCNO>
	<brief_summary>This study estimate fast two antiepileptic drug ( Levetiracetam Brivaracetam ) enter human brain . Brain imaging use measure quickly radioactive probe [ 11C ] UCB-J exit brain Levetiracetam Brivaracetam give intravenously . This used estimate fast antiepileptic drug enter brain .</brief_summary>
	<brief_title>A Brain Imaging Study With Positron Emission Tomography Radiotracer 11CUCB-J Estimate How Fast Brivaracetam Levetiracetam Enter Brain Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subject male female 18 55 year age ( inclusive ) Subject good physical mental health , opinion Investigator , determine basis medical history , physical neurological examination , vital sign , 12lead Electrocardiography ( ECG ) , clinical laboratory test Female subject childbearing potential must negative pregnancy test ; female subject childbearing potential confirm , 1 month prior first administration study medication entire study Safety FollowUp ( SFU ) Visit either use highly effective contraceptive method ( eg , oral contraception , intrauterine device , diaphragm spermicide ) abstain sexual activity cause pregnancy History presence clinically significant respiratory , gastrointestinal , renal , hepatic , pancreatic , hematological , cardiovascular , musculoskeletal , genitourinary , immunological , dermatological disorder , type cancer Subject history neurological diagnosis , include limited stroke , traumatic brain injury , epilepsy , space occupy lesion , multiple sclerosis , Parkinson 's disease , vascular dementia , transient ischemic attack , neurological disorder may influence outcome analysis scan result History donation 450 mL blood within 60 day prior dose Yale PET center plan donation 30 day elapse since intake study drug The subject Magnetic Resonance Imaging incompatible ( MRI incompatible ) implant contraindication MRI , pacemaker , artificial joint , nonremovable body piercings , etc . Subjects receive diagnostic therapeutic radiopharmaceutical le 7 day prior participation study Participation recent research study &lt; 1 month &lt; 1 year study involve ionizing radiation would cause subject exceed yearly dose limit healthy volunteer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>SV2A</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Brivaracetam</keyword>
	<keyword>PET</keyword>
</DOC>